A phase I study of an anti-CD30 x anti-CD16A bispecific tandab antibody, AFM13, in patients with relapsed or refractory Hodgkin lymphoma Meeting Abstract
| Authors: | Zhukovsky, E.; Rothe, A.; von Tresckow, B.; Topp, M.; Younes, A.; Eichenauer, D. A.; Hummel, H.; Reiners, K. S.; Dietlein, M.; Kessler, J.; Ravic, M.; Hucke, C.; Strandmann, E. P.; Engert, A. |
| Abstract Title: | A phase I study of an anti-CD30 x anti-CD16A bispecific tandab antibody, AFM13, in patients with relapsed or refractory Hodgkin lymphoma |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385008493 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.5116.5116 |
| Notes: | Meeting Abstract: 5116 -- Source: Wos |
